ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
154.03
-3.5700
-2.27%
盤前:
154.55
0.5150
+0.33%
06:23 EDT
成交量:
1,130.06萬
成交額:
17.39億
市值:
105.01億
市盈率:
8.45
高:
157.53
開:
157.08
低:
152.63
收:
157.60
52周最高:
169.89
52周最低:
93.26
股本:
6,817.50萬
流通股本:
6,817.50萬
量比:
1.47
換手率:
16.58%
股息:
0.57
股息率:
0.37%
每股收益(TTM):
18.23
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
傳童牧知擬加盟瑞銀 出任集團亞洲醫療保健投行業務主席
智通财经
·
08/18
亞太藥業等成立生物科技公司
智通财经
·
08/18
醫療保健板塊動態:市場快訊匯總
投资观察
·
08/18
醫療板塊動態:市場快訊匯總
投资观察
·
08/18
瑞銀據悉延攬高盛前老將 將負責亞洲醫療保健投行業務
智通财经
·
08/17
全球資產配置進入「去擁擠化」時刻!美銀從AI算力轉向價值、生物科技與大宗商品
智通财经
·
08/17
醫藥基金淨值大幅攀升 機構配置尚處歷史低位
智通财经
·
08/17
槍殺美國聯合健康保險CEO的曼吉奧內就聯邦指控認罪
澎湃新闻
·
08/15
路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁
每日经济新闻
·
08/15
路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁
每日经济新闻
·
08/15
路易吉・曼喬內在法庭上承認,他槍擊了聯合健康保險原首席執行官布萊恩・湯普森。
智通财经
·
08/14
惠譽: 隨着醫療保險和社會保障支出到 2032 年將接近增加 1 個百分點的國內生產總值,財政壓力將會加劇。
智通财经
·
08/14
「人才版圖」引領 繪就生物醫藥千億「產業藍圖」
经济参考报
·
08/14
醫療保健板塊快訊:市場動態綜述
投资观察
·
08/14
醫療保健板塊綜述:市場快訊
投资观察
·
08/13
上海:完善上海市重點產業地圖,聚焦集成電路、生物醫藥、人工智能三大先導產業
智通财经
·
08/13
民祥生物醫藥被出具警示函,涉未披露年報等
蓝鲸财经
·
08/12
花旗(C.US)調整北美醫療健康投行團隊 強化醫療賽道核心競爭力
智通财经
·
08/12
辰欣藥業等成立生物科技公司
智通财经
·
08/12
生物醫藥賽道迎來機構扎堆調研 商業化與全球化進展成關注重點
智通财经
·
08/12
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/XBI/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":154.03,"timestamp":1789502400000,"preClose":157.6,"halted":0,"volume":11300561,"hourTrading":{"tag":"盘前","latestPrice":154.545,"preClose":154.03,"latestTime":"06:23 EDT","volume":1351,"amount":208903.69794,"timestamp":1789554235033,"change":0.515,"changeRate":0.003344,"amplitude":0.005363},"delay":0,"changeRate":-0.02265228426395935,"floatShares":68175000,"shares":68175000,"eps":18.23,"marketStatus":"盤前交易","change":-3.57,"latestTime":"09-16 06:25:51 EDT","open":157.08,"high":157.53,"low":152.63,"amount":1738536841.14598,"amplitude":0.031091,"askPrice":154.7,"askSize":400,"bidPrice":154,"bidSize":400,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.03,"sharesOutstanding":63325000,"nav":157.586874,"aum":10743485169.21,"dividendRate":0.0037,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":154.545,"preClose":154.03,"latestTime":"06:23 EDT","volume":1351,"amount":208903.69794,"timestamp":1789554235033,"change":0.515,"changeRate":0.003344,"amplitude":0.005363},"postHourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"volumeRatio":1.4749354161726091,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1792123200000,"strike":"150.0","timestamp":1789502340274,"price":3.85,"volume":15000,"amount":5775000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"158.0","timestamp":1789502340274,"price":4.52,"volume":15000,"amount":6780000,"type":"-"}]},"impliedVol":0.319,"impliedVolPercentile":0.62},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":68175000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.4749354161726091,"shares":68175000,"dividePrice":0.5699,"high":157.53,"amplitude":0.031091,"preClose":157.6,"low":152.63,"week52Low":93.26,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.03,"eps":18.23,"divideRate":0.0037,"volume":11300561,"delay":0,"ttmEps":18.23,"open":157.08,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":161.93,"twentyDayClose":159.53,"sixtyDayClose":140.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660683452","title":"傳童牧知擬加盟瑞銀 出任集團亞洲醫療保健投行業務主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2660683452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660683452?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 14:08","pubTimestamp":1787033333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据媒体引述知情人士透露,已从高盛离职的资深投行家童牧知(Samuel Thong),拟于10月加入瑞银集团、出任瑞银亚洲医疗保健投资银行业务主席一职。资料显示,童牧知博士在医疗保健投资银行领域深耕多年,是一位资深的医疗保健投行家,从业时间约30年,拥有芝加哥大学医学博士、MBA学位。2019年,他从摩根士丹利跳槽至高盛,出任高盛投资银行部亚洲(除日本)医疗保健团队主席,并兼任该团队联席主管。于今年早些时候,他从高盛离职。在加入摩根士丹利负责亚洲医疗保健投行业务之前,他曾任职于美银美林。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IEFN","JHMF","VHT","BK4585","BK4581","BCFN","BNKO","BNKZ","KNAB","FAS","BK4582","LABU","XBI","BK4588","IAI","XLFI","BK4550","NOBL","XLV","CGVV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660945692","title":"亞太藥業等成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2660945692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660945692?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 10:32","pubTimestamp":1787020356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SYNB","MEDX","IBBJ","XBI","LNGR","BK4588","BK4585","AGNG","IEIH","BK4581","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176123870","title":"醫療保健板塊動態:市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1176123870","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176123870?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 04:54","pubTimestamp":1787000078,"startTime":"0","endTime":"0","summary":"涵盖医疗保健领域的最新市场快讯,于美国东部时间4:20、12:20及16:50在道琼斯通讯社独家发布。根据协议,两家公司将携手推进多达十种生物类似药的开发与商业化,商业化相关付款总额最高可达3.22亿美元。塞夫顿表示,此项协议\"彰显了山德士在生物类似药商业化合作领域的领先地位\"。该药物占阿斯利康为其设定的超过50亿美元销售目标的约20%。该公司股价下跌1.2%,报0.83新加坡元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169996683","title":"醫療板塊動態:市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1169996683","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169996683?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 00:26","pubTimestamp":1786983993,"startTime":"0","endTime":"0","summary":"医疗健康领域最新市场快讯,涵盖制药巨头动态与行业投资风向。根据协议,双方将共同推进多达十种生物类似药的开发与商业化,商业化相关付款总额最高可达3.22亿美元。消息公布后,山德士股价上涨3.15%,报75.3瑞士法郎。0620 GMT——摩根大通分析师认为,阿斯利康终止一项肺癌药物试验虽令人失望,但其他药物的积极数据可能推动市场对其销售指引预期上调。该股下跌1.2%,报0.83新加坡元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4585","XBI","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101918","title":"瑞銀據悉延攬高盛前老將 將負責亞洲醫療保健投行業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101918","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101918?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:24","pubTimestamp":1786937087,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4582","LU2750360997.AUD","LU2750360641.GBP","IE0004086264.USD","LU0048573561.USD","LU0251142724.SGD","LU2237443382.USD","LU2237443978.SGD","IEFN","LU2471134952.CNY","LU1894683264.USD","XLV","LU0868494708.USD","IAI","IE0002270589.USD","XBI","GSX","IE00B19Z3B42.SGD","BNKZ","JHMF","LU1804176565.USD","XLFI","BK4127","LU1668664300.SGD","NOBL","BCFN","BK4550","FAS","BK4552","BK4588","LU2471134879.HKD","BK4516","VHT","LABU","CGVV","LU0061475181.USD","BNKO","LU0942090050.USD","LU2237443465.HKD","LU1868837136.USD","IE00B19Z3581.USD","KNAB","LU2237443895.HKD","GS","LU2237443549.SGD","LU2237443622.USD","LU1791807156.HKD","LU1868836757.USD","LU0106831901.USD","LU2471134796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105476","title":"全球資產配置進入「去擁擠化」時刻!美銀從AI算力轉向價值、生物科技與大宗商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105476?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 09:15","pubTimestamp":1786929314,"startTime":"0","endTime":"0","summary":"不过,该行警告称,从长期来看,最大规模的增量收益可能最终流向消费者和全球整体经济,而不是那些为大规模建设AI算力基础设施提供支持的科技企业。因此,美国银行转而看好大宗商品和其他实物资产。","market":"us","thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92a7f5f4aa264c2793397c9dc1d602d4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480529.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":[".SPX","QDEC","QID","PSQ","GAA","ITDJ","03455","09834","EUCG","TRIO","QPX","BTR","AGOX","QLD","QALT",".IXIC","NMBL","YSPY","SDOW","NJUL","PCPP","QQQ","TCTL","NDAA","SPYU","XBI","GDMA","SH","SPXL","UDOW","DOG","07522","SQQQ","SSO","NDX","BK4581","LEXI","AVMA","WDAI","KOOL","GPIQ","GMOM","161715","KNOW","MEDX","07266","DXD","GDOC","SPY","DDX","SPDN","03034",".DJI","02834","QQQX","07568","MMAX","159837","NJAN","SMAX","SPYH","RNMN","IVV","03086","SPXU","DRAI","WLTG","SDS","EEV","ARP","07261","LNGR","NOCT","QQQM","NTSI","TBFG","BK4585","IEIH","DMAX","SPYM","ITDF","UPRO","ITDI","GAL","SYNB","DIA","WISE","FPAA","IBBJ","MVFG","SPUU","SPXS","TQQQ","VOO","DDM","09086","SPYQ","BK4588","QMAR","HIBL","TQQY","NAPR","AGNG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2660108069","title":"醫藥基金淨值大幅攀升 機構配置尚處歷史低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2660108069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660108069?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 06:17","pubTimestamp":1786918664,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","XLV","BK4581","BK4585","XBI","VHT","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659131127","title":"槍殺美國聯合健康保險CEO的曼吉奧內就聯邦指控認罪","url":"https://stock-news.laohu8.com/highlight/detail?id=2659131127","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659131127?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 09:50","pubTimestamp":1786758600,"startTime":"0","endTime":"0","summary":"据CCTV国际时讯消息,8月14日,被控枪杀美国联合健康保险公司首席执行官布赖恩·汤普森(BrianThompson)的路易吉·曼吉奥内在法庭上表示,他就其联邦刑事案件认罪,承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。此外,认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控,并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842363652.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842363652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","XBI","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659552127","title":"路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659552127","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659552127?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753353,"startTime":"0","endTime":"0","summary":"当地时间8月14日,路易吉·曼吉奥内就枪杀联合健康保险首席执行官布赖恩·汤普森(BrianThompson)一案正式认罪。联邦法官将路易吉·曼吉奥内的量刑日期定于12月18日。路易吉·曼吉奥内当天在法庭上表示,他就其联邦刑事案件认罪,承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842343196.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842343196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","BK4585","LABU","BK4588","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659276311","title":"路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659276311","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659276311?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753320,"startTime":"0","endTime":"0","summary":"路易吉·曼吉奥内当天在法庭上表示,他就其联邦刑事案件认罪,承认自己枪杀了汤普森。此外,认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控,并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。州级指控方面,曼吉奥内此前面临二级谋杀、非法持有武器、持有虚假身份证明等多项罪名指控。如果二级谋杀罪名成立,曼吉奥内将面临25年至终身监禁的刑罚。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128599","title":"路易吉・曼喬內在法庭上承認,他槍擊了聯合健康保險原首席執行官布萊恩・湯普森。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128599?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:40","pubTimestamp":1786722026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XBI","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167007","title":"惠譽: 隨着醫療保險和社會保障支出到 2032 年將接近增加 1 個百分點的國內生產總值,財政壓力將會加劇。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 04:39","pubTimestamp":1786653589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XBI","BK4585","BK4581","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164273","title":"「人才版圖」引領 繪就生物醫藥千億「產業藍圖」","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164273","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164273?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 03:50","pubTimestamp":1786650640,"startTime":"0","endTime":"0","summary":"研发出首个幽门螺杆菌创新药的丹诺医药成功登陆香港联交所,用于治疗胃癌的1类创新药安尼妥单抗注射液正式获批上市,精神分裂症治疗创新药凯捷乐从苏州首发销往全国……今年以来,苏州工业园区生物医药板块“捷报”频传。生物医药创新成果竞相涌现的背后,离不开引领产业发展的人才支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608143840851846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608143840851846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","161726","XBI","399441","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141376784","title":"醫療保健板塊快訊:市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1141376784","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141376784?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 00:24","pubTimestamp":1786638273,"startTime":"0","endTime":"0","summary":"医疗保健行业最新市场动态速览。该报道内容精选自专题市场快讯。该协会援引内部调查数据称,从去年1月到今年6月,Interpharma的成员企业,在总共22款新药中,有7款拒绝向瑞士医保机构提交报销申请。Interpharma表示,为了不危及美国市场的定价,药企往往会搁置其研发的新药,平均每三款就有一款暂停提交申请。KPJ Healthcare第二季度核心净利润预计将环比走强。该股目前股价持平,报3.07林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4581","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161156613","title":"醫療保健板塊綜述:市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1161156613","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161156613?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 16:24","pubTimestamp":1786609477,"startTime":"0","endTime":"0","summary":"以下为最新医疗保健板块市场快讯,内容涵盖亚太及北美市场动态。RHB维持对KPJ的“买入”评级,目标股价定为3.77林吉特。Apotex公司在公开市场首秀中,其美国业务部门成为明显的软肋。该丹麦制药商的CEO似乎对减肥药丸市场的前景非常乐观,但贝伦贝格认为,诺和诺德可能需要通过交易来增加更多的口服药物,以维持其领先地位。贝伦贝格将诺和诺德股票的评级从“买入”下调至“持有”,并将目标价从325丹麦克朗下调至305丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182162","title":"上海:完善上海市重點產業地圖,聚焦集成電路、生物醫藥、人工智能三大先導產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659182162?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 10:14","pubTimestamp":1786587282,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09834","ARTY","NOCT","OGIG","QQA","AGIX","AIBU","GK","NAPR","09086","LCLG","NJAN","DQJN","AQGX","QSWN","QQQ","AIQU","FWD","NBDS","WPAI","TQQQ","03086","NJUL","QQQM","TARK","KOMP","CHAT","TECY","GPIQ","XBI","AIFD","QTOC","MFIG","07266","VUSE","03034","03455","MVPS","NEWZ","QQQX","QMAR","SQQQ","CWC","PSQ","TQQY","QDEC","QLD","CPNQ","QID","PBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974771","title":"民祥生物醫藥被出具警示函,涉未披露年報等","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974771","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974771?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:44","pubTimestamp":1786535098,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月12日讯,近日,天津证监局发布行政监管措施决定书,剑指天津民祥生物医药股份有限公司及相关责任人。决定书显示,民祥医药存在以下情形:未按规定披露2025年年度报告,补充披露相关人事及股东会决议公告不及时,为子公司提供担保未履行审议程序及信息披露义务。以上行为违反了《非上市公众公司监督管理办法》和《非上市公众公司信息披露管理办法》的相关规定。公司董事长刘万里、副总经理兼董秘张毅对上述违规事项负有责任。针对上述违法行为,天津证监局对民祥医药、刘万里、张毅采取出具警示函的监督管理措施,记入证券期货市场诚信档案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786526206112430419","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["161726","BK4581","XBI","399441","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658921870","title":"花旗(C.US)調整北美醫療健康投行團隊 強化醫療賽道核心競爭力","url":"https://stock-news.laohu8.com/highlight/detail?id=2658921870","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658921870?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 14:25","pubTimestamp":1786515916,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,花旗集团近日为医疗健康投行业务线新任命多名主管,计划借此提升行业地位,在火热的医疗赛道强化核心竞争力。全球医疗健康投行主管Sumit Khedekar发布内部备忘录称,本次调整敲定了北美地区生物科技、医疗器械、生物制药等多个医疗细分领域新任负责人人选。花旗银行业务主管Vis Raghavan今年5月在投资者大会上明确指出,医疗健康与科技、工业板块并列为三大高增长赛道,是花旗投行团队的重点攻坚方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2462157665.USD","LU1201861249.SGD","LU0128525689.USD","LU1366192091.USD","LU0052756011.USD","LU2125154935.USD","LU2456880835.USD","LU0170899867.USD","XLV","BK4588","BK4566","BK4585","LU1267930227.SGD","TFNS","LU2417539215.USD","LU0203345920.USD","LU1244550577.SGD","LU0648001328.SGD","LU0980610538.SGD","LU1791807156.HKD","VHT","159891","LU0162691827.USD","LU2360032135.SGD","LU0314106906.USD","LU1162221912.USD","LU0130517989.USD","LU1244550221.USD","FTXO","IYF","LABU","LU0098860793.USD","LU0106831901.USD","LU1074936037.SGD","LU0310800965.SGD","BK4207","BK4559","BK4581","LU0130102774.USD","BK4504","BK4550","IXJ","LU1506573853.SGD","LU0072461881.USD","LU2236285917.USD","XBI","LU1668664300.SGD","LU0203347892.USD","LU0320765646.SGD","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658092329","title":"辰欣藥業等成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658092329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658092329?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 12:37","pubTimestamp":1786509464,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LNGR","AGNG","IEIH","MEDX","IBBJ","SYNB","GDOC","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658941844","title":"生物醫藥賽道迎來機構扎堆調研 商業化與全球化進展成關注重點","url":"https://stock-news.laohu8.com/highlight/detail?id=2658941844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658941844?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 07:02","pubTimestamp":1786489344,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}